The proliferative response of NB69 human neuroblastoma cells to a 50 Hz magnetic field is mediated by ERK1/2 signaling

Cellular Physiology and Biochemistry

Volumn 29, Issue 5-6, 2012, Pages 675-686

  Martínez, María Antonia ^a   Úbeda, Alejandro ^a   Cid, María Antonia ^b   Trillo, María Ángeles ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

ELF; ERK1 2; Magnetic fields; Neuroblastoma; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CELL COUNT; CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN NB69; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MAGNETIC FIELD; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

EID: 84861353611     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000178457     Document Type: Article

References (53)

1. Feychting M, Ahlbom A, Kheifets L: EMF and health. Annu Rev Public Health 2005;26:165-189. (Pubitemid 40547380)
2. Hug K, Röösli M, Rapp R: Magnetic field exposure and neurodegenerative diseases recent epidemiological studies. Soz Praventivmed 2006;51:210-220. (Pubitemid 44420288)
3. Kheifets L, Bowman JD, Checkoway H, Feychting M, Harrington JM, Kavet R, Marsh G, Mezei G, Renew DC, van Wijngaarden E: Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: Review and recommendations. Occup Environ Med 2009;66:72-80.
4. Kheifets L, Ahlbom A, Crespi CM, Draper G, Hagihara J, Lowenthal RM, Mezei G, Oksuzyan S, Schüz J, Swanson J, Tittarelli A, Vinceti M, Wunsch Filho V: Pooled analysis of recent studies on magnetic fields and childhood leukaemia. Br J Cancer 2010;103:1128-1135.
5. International Agency for Research of Cancer (IARC): IARC monograph on the evaluation of carcinogenic risks to humans, Vol. 80. Non-ionizing radiation, Part 1: Static and extremely low-frequency (ELF) electric and magnetic fields. Lyon, France: IARC Press. 2002. Retrieved from: http://monographs.iarc.fr/ENG/ Monographs/vol80/mono80.pdf. (Last accessed 20 December 2011).
6. National Institute of Environmental Health Sciences (NIEHS): Assessment of health effects from exposure to power line frequency electric and magnetic fields. Working Group Report. Christopher J. Portier, Ph. D. Mary S. Wolfe, Ph. D. Editors. 1-508, 1998. Retrieved from: http://niremf.ifac.cnr.it/docs/niehs98. pdf. [Last accessed 20 December 2011]
7. Schüz J, Lagorio S, Bersani F: Electromagnetic fields and epidemiology: an overview inspired by the fourth course at the International School of Bioelectromagnetics. Bioelectromagnetics 2009;30:511-524.
8. Santini MT, Rainaldi G, Indovina PL: Cellular effects of extremely low frequency (ELF) electromagnetic fields. Int J Radiat Biol 2009;85:294-313.
9. Wolf FI, Torsello A, Tedesco B, Fasanella S, Boninsegna A, D'Ascenzo M, Grassi C, Azzena GB, Cittadini A: 50-Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: possible involvement of a redox mechanism. Biochim Biophys Acta 2005;1743:120-129. (Pubitemid 40380612)
10. Ayse IG, Zafer A, Sule O, Isil IT, Kalkan T: Differentiation of K562 cells under ELF-EMF applied at different time courses. Electromagn Biol Med 2010;29:122-130.
11. Basile A, Zeppa R, Pasquino N, Arra C, Ammirante M, Festa M, Barbieri A, Giudice A, Pascale M, Turco MC, Rosati A: Exposure to 50 Hz electromagnetic field raises the levels of the antiapoptotic protein BAG3 in melanoma cells. J Cell Physiol 2011;226:2901-2907.
12. International Commission on Non-Ionising Radiation Protection (ICNIRP): Guidelines for limiting exposure to timevarying electric, magnetic, and electromagnetic fields (up to 300 GHz). Health Phys 1998;74:494-522.
13. 2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium 2004;35:307-315. (Pubitemid 38351200)
14. Eleuteri AM, Amici M, Bonfili L, Cecarini V, Cuccioloni M, Grimaldi S, Giuliani L, Angeletti M, Fioretti E: 50 Hz extremely low frequency electromagnetic fields enhance protein carbonyl groups content in cancer cells: effects on proteasomal systems. J Biomed Biotechnol 2009;2009:1-10.
15. Tofani S, Barone D, Cintorino M, de Santi MM, Ferrara A, Orlassino R, Ossola P, Peroglio F, Rolfo K, Ronchetto F: Static and ELF magnetic fields induce tumor growth inhibition and apoptosis. Bioelectromagnetics 2001;22:419-428. (Pubitemid 33617704)
16. Tofani S, Barone D, Berardelli M, Berno E, Cintorino M, Foglia L, Ossola P, Ronchetto F, Toso E, Eandi M: Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol Res 2003;48:83-90. (Pubitemid 36593362)
17. Pozzi D, Grimaldi S, Ledda M, De Carlo F, Modesti A, Scarpa S, Foletti A, Lisi A: Effect of 50 Hz magnetic field on neuroblastoma morphology. Int J Integrative Biol 2007;1:12-17.
18. Yoshizawa H, Tsuchiya T, Mizoe H, Ozeki H, Kanao S, Yomori H, Sakane C, Hasebe S, Motomura T, Yamakawa T, Mizuno F, Hirose H, Otaka Y: No effect of extremely low-frequency magnetic field observed on cell growth or initial response of cell proliferation in human cancer cell lines. Bioelectromagnetics 2002;23:355-368. (Pubitemid 38622879)
19. Ivancsits S, Diem, E, Pilger A, Rüdiger HW, Jahn O: Induction of DNA strand breaks by intermittent exposure to extremely low-frequency electromagnetic fields in human diploid fibroblast. Mutat Res 2002;519:1-13. (Pubitemid 34874982)
20. Ivancsits S, Pilger A, Diem E, Jahn O, Rüdiger HW: Cell type-specific genotoxic effects of intermittent extremely lowfrequency electromagnetic fields. Mutat Res 2005;583:184-188. (Pubitemid 40775915)
21. Simko M: Cell type specific redox status is responsible for diverse electromagnetic field effects. Curr Med Chem 2007;14:1141-1152. (Pubitemid 46672632)
22. Piacentini R, Ripoli C, Mezzogori D, Azzena GB, Grassi C: Extremely low-frequency electromagnetic fields promote in vitro neurogenesis via upregulation of Cav 1-channel activity. J Cell Physiol 2008;215:129-139. (Pubitemid 351363198)
23. Focke F, Schuermann D, Kuster N, Schär P: DNA fragmentation in human fibroblasts under extremely low frequency electromagnetic field exposure. Mutat Res 2010;683:74-83.
24. Kim J, Ha CS, Lee HJ, Song K: Repetitive exposure to a 60-Hz time-varying magnetic field induces DNA double-strand breaks and apoptosis in human cells. Biochem Biophys Res Commun 2010;400:739-744.
25. Shaul YD, Seger R: The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 2007;1773:1213-1226. (Pubitemid 47125968)
26. Meloche S, Pouysségur J: The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene 2007;26:3227-3239. (Pubitemid 46763017)
27. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007;1173:1263-1284. (Pubitemid 47125967)
28. Steelman LS, Franklin RA, Abrams SL, Chappell W, Kempf CR, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo P, Ruvolo V, Evangelisti C, Martelli AM, McCubrey JA: Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. Leukemia 2011;25:1080-1094.
29. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-183. (Pubitemid 32458157)
30. Jin M, Blank M, Goodman R: ERK1/2 phosphorylation induced by electromagnetic fields, diminishes during neoplasic transformation. J Cell Biochem 2000;78:371-379. (Pubitemid 30491066)
31. Nie K, Henderson A: MAP kinase activation in cells exposed to a 60 Hz electromagnetic field. J Cell Biochem 2003;90:1197-1206. (Pubitemid 37485055)
32. Trillo MA, Martínez MA, Cid MA, García VJ, Ubeda, A, and Leal, J. 2003: Action of 50 Hz magnetic fields on the growth of human neuroblastoma cells. 25th BEMS Meeting, Maui, Hawaii, Abstract Book: 287. Retrieved from http://www.bioelectromagnetics.org/doc/bems2003-abstracts.pdf [Last accessed 20 December 2011]
33. REFLEX-Project 2004: Risk evaluation of potential environmental hazards from low energy electromagnetic field exposure using sensitive in vitro methods. Final Report. Retrieved from: http://www.powerwatch.org.uk/pdfs/20041222- reflex.pdf. (Last accessed 20 December 2011).
34. Trillo MA, Martínez MA, Cid MA, Leal J, Ubeda A: Influence of a 50 Hz magnetic field and of all-trans-retinol on the proliferation of human cancer cell lines. Int J Oncol 2012;40:1405-1413.
35. Winker R, Ivancsits S, Pilger A, Adlkofer F, Rudiger HW: Chromosomal damage in human diploid fibroblasts by intermittent exposure to extremely low-frequency electromagnetic fields. Mutat Res 2005;585:43-49. (Pubitemid 40980417)
36. Balmanno K, Cook SJ: Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 2009;16:368-377.
37. Kim EK, Choi EJ: Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010;1802:396-405.
38. Goodman R, Blank M: Insights into electromagnetic interaction mechanisms. J Cellular Physiology 2002;192:16-22. (Pubitemid 34587383)
39. Goodman R, Lin-Ye A, Geddis MS, Wickramaratne PJ, Hodge SE, Pantazatos S, Blank M, Ambron RT: Extremely low frequency electromagnetic fields activate the ERK cascade, increase hsp70 protein levels and promote regeneration in Planaria. Int J Radiat Biol 2009;85:851-859.
40. Ebisuya M, Kondoh K, Nishida E: The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanism for providing signalling specificity. J Cell Sci 2005;118:2997-3002. (Pubitemid 41149904)
41. Lee RH, Wong WL, Chan CH, Chan SY: Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells. J Neurosci Res 2006;83:80-90. (Pubitemid 43062012)
42. Jia C, Zhou Z, Liu R, Chen S, Xia R: EGF receptor clustering is induced by a 0.4 mT power frequency magnetic field and blocked by the EGF receptor tyrosine kinase inhibitor PD153035. Bioelectromagnetics 2007;28:197-207. (Pubitemid 46555876)
43. Sun W, Gan Y, Fu Y, Lu D, Chiang H: An incoherent magnetic field inhibited EGF receptor clustering and phosphorylation induced by a 50-Hz magnetic field in cultured FL cells. Cell Physiol Biochem 2008;22:507-514.
44. Ke XQ, Sun WJ, Lu DQ, Fu YT, Chiang H: 50-Hz magnetic field induces EGFreceptor clustering and activates RAS. Int J Radiat Biol 2008;84:413-20. (Pubitemid 351878840)
45. Mitton B, Cho EC, Aldana-Masangkay GI, Sakamoto KM: The function of cyclicadenosine monophosphate responsive element-binding protein in hematologic malignancies. Leuk Lymphoma 2011;52:2057-2063.
46. Sakamoto KM, Frank DA: CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res 2009;15:2583-25877.
47. 2+ but not PKA, PKC, ERK, or p38 MAPK. Biochem Biophys Res Commun 2002;296:1013-1018.
48. Tonini R, Baroni MD, Masala E, Micheletti M, Ferroni A, Mazzanti M: Calcium protect differentiating neuroblastoma cells during 50 Hz electromagnetic radiation. Biophys J 2001;81:2580-2589. (Pubitemid 33020046)
49. Blackman CF, Benane SG, Kinney LS, House DE, Joines WT: Effects of ELF fields on calcium-ion efflux from brain tissue, in vitro. Radiat Res 1982;92:510-520. (Pubitemid 13221305)
50. Blackman CF, Benane SG, House DE, Joines WT, Spiegel RJ: Effect of ambient levels of power-line-frequency electric fields on a developing vertebrate. Bioelectromagnetics 1988;9:129-140.
51. Adey WR: Cell membranes: the electromagnetic environment and cancer promotion. Neurochem Res 1988;13:671-677.
52. Adey WR: The cellular microenvironment and signaling through cell membranes. Prog Clin Biol Res 1988;257:81-106.
53. Adey WR: Biological effects of electromagnetic fields. J Cell Biochem 1993;51:410-416. (Pubitemid 23114272)